Year |
Citation |
Score |
2019 |
Webster MR, Fane ME, Alicea GM, Basu S, Kossenkov AV, Marino GE, Douglass SM, Kaur A, Ecker BL, Gnanapradeepan K, Ndoye A, Kugel C, Valiga A, Palmer J, Liu Q, et al. Paradoxical Role for Wild-Type p53 in Driving Therapy Resistance in Melanoma. Molecular Cell. PMID 31836388 DOI: 10.1016/J.Molcel.2019.11.009 |
0.323 |
|
2019 |
Veglia F, Tyurin VA, Blasi M, De Leo A, Kossenkov AV, Donthireddy L, To TKJ, Schug Z, Basu S, Wang F, Ricciotti E, DiRusso C, Murphy ME, Vonderheide RH, Lieberman PM, et al. Fatty acid transport protein 2 reprograms neutrophils in cancer. Nature. PMID 30996346 DOI: 10.1038/S41586-019-1118-2 |
0.313 |
|
2019 |
Parris J, Basu S, Barnoud T, Zhao Y, Somboonsong P, Chen Q, Murphy M. Abstract 4847: Investigating the impact of astrocytes on targeted therapy of melanoma brain metastases Cancer Research. 79: 4847-4847. DOI: 10.1158/1538-7445.Sabcs18-4847 |
0.316 |
|
2019 |
Gnanapradeepan K, Basu S, Kung C, Barnoud T, Good M, Quinn W, Lee J, Wellen K, Schug Z, Baur J, George D, Murphy M. Abstract 3483: The African-specific S47 variant of the p53 tumor suppressor gene alters cell metabolism Cancer Research. 79: 3483-3483. DOI: 10.1158/1538-7445.Am2019-3483 |
0.354 |
|
2018 |
Barnoud T, Budina-Kolomets A, Basu S, Leu JI, Good M, Kung CP, Liu J, Liu Q, Villanueva J, Zhang R, George DL, Murphy ME. Tailoring chemotherapy for the African-centric S47 variant of TP53. Cancer Research. PMID 30115697 DOI: 10.1158/0008-5472.Can-18-1327 |
0.341 |
|
2018 |
Gnanapradeepan K, Basu S, Barnoud T, Budina-Kolomets A, Kung CP, Murphy ME. The p53 Tumor Suppressor in the Control of Metabolism and Ferroptosis. Frontiers in Endocrinology. 9: 124. PMID 29695998 DOI: 10.3389/Fendo.2018.00124 |
0.356 |
|
2018 |
Basu S, Gnanapradeepan K, Barnoud T, Kung CP, Tavecchio M, Scott J, Watters A, Chen Q, Kossenkov AV, Murphy ME. Mutant p53 controls tumor metabolism and metastasis by regulating PGC-1α. Genes & Development. PMID 29463573 DOI: 10.1101/Gad.309062.117 |
0.354 |
|
2018 |
Barnoud T, Basu S, Kung C, Reiss M, Zhang R, Murphy M. Abstract B210: BET inhibitors show superior ability to suppress the progression of tumors containing the Pro47Ser single-nucleotide polymorphism of p53 Molecular Cancer Therapeutics. 17. DOI: 10.1158/1535-7163.Targ-17-B210 |
0.347 |
|
2017 |
Webster MR, Kaur A, Ndoye A, Kugel C, Basu S, Valiga A, Appleton J, Wang Y, Murphy M, Weeraratna AT. Abstract 4913: Invasive melanoma cells commandeer p53 activity to promote the survival of a therapy resistant subpopulation Cancer Research. 77: 4913-4913. DOI: 10.1158/1538-7445.Am2017-4913 |
0.407 |
|
2016 |
Chatwichien J, Basu S, Budina-Kolomets A, Murphy ME, Winkler JD. PUMA-dependent apoptosis in NSCLC cancer cells by a dimeric β-carboline. Bioorganic & Medicinal Chemistry Letters. PMID 27650927 DOI: 10.1016/J.Bmcl.2016.09.030 |
0.348 |
|
2016 |
Basu S, Barnoud T, Kung CP, Reiss M, Murphy ME. The African-specific S47 polymorphism of p53 alters chemosensitivity. Cell Cycle (Georgetown, Tex.). 0. PMID 27484708 DOI: 10.1080/15384101.2016.1215390 |
0.373 |
|
2016 |
Basu S, Murphy ME. p53 family members regulate cancer stem cells. Cell Cycle (Georgetown, Tex.). 0. PMID 27057793 DOI: 10.1080/15384101.2016.1171649 |
0.363 |
|
2016 |
Basu S, Murphy ME. Genetic Modifiers of the p53 Pathway. Cold Spring Harbor Perspectives in Medicine. 6. PMID 27037420 DOI: 10.1101/Cshperspect.A026302 |
0.345 |
|
2016 |
Jennis M, Kung CP, Basu S, Budina-Kolomets A, Leu JI, Khaku S, Scott JP, Cai KQ, Campbell MR, Porter DK, Wang X, Bell DA, Li X, Garlick DS, Liu Q, et al. An African-specific polymorphism in the TP53 gene impairs p53 tumor suppressor function in a mouse model. Genes & Development. PMID 27034505 DOI: 10.1101/Gad.275891.115 |
0.395 |
|
2016 |
Kung CP, Leu JI, Basu S, Khaku S, Anokye-Danso F, Liu Q, George DL, Ahima RS, Murphy ME. The P72R Polymorphism of p53 Predisposes to Obesity and Metabolic Dysfunction. Cell Reports. PMID 26947067 DOI: 10.1016/J.Celrep.2016.02.037 |
0.311 |
|
2015 |
Webster MR, Basu S, Kaur A, Appleton J, Murphy ME, Weeraratna AT. Abstract 3775: p53 is differentially regulated in proliferative and invasive melanoma cells Cancer Research. 75: 3775-3775. DOI: 10.1158/1538-7445.Am2015-3775 |
0.378 |
|
2014 |
Chauss D, Basu S, Rajakaruna S, Ma Z, Gau V, Anastas S, Brennan LA, Hejtmancik JF, Menko AS, Kantorow M. Differentiation state-specific mitochondrial dynamic regulatory networks are revealed by global transcriptional analysis of the developing chicken lens. G3 (Bethesda, Md.). 4: 1515-27. PMID 24928582 DOI: 10.1534/G3.114.012120 |
0.614 |
|
2014 |
Basu S, Rajakaruna S, Reyes B, Van Bockstaele E, Menko AS. Suppression of MAPK/JNK-MTORC1 signaling leads to premature loss of organelles and nuclei by autophagy during terminal differentiation of lens fiber cells. Autophagy. 10: 1193-211. PMID 24813396 DOI: 10.4161/Auto.28768 |
0.614 |
|
2014 |
Basu S, Rajakaruna S, Dickinson BC, Chang CJ, Menko AS. Endogenous hydrogen peroxide production in the epithelium of the developing embryonic lens. Molecular Vision. 20: 458-67. PMID 24744606 |
0.571 |
|
2014 |
Basu S, Rajakaruna S, De Arcangelis A, Zhang L, Georges-Labouesse E, Menko AS. α6 integrin transactivates insulin-like growth factor receptor-1 (IGF-1R) to regulate caspase-3-mediated lens epithelial cell differentiation initiation. The Journal of Biological Chemistry. 289: 3842-55. PMID 24381169 DOI: 10.1074/Jbc.M113.515254 |
0.631 |
|
2013 |
Costello MJ, Brennan LA, Basu S, Chauss D, Mohamed A, Gilliland KO, Johnsen S, Menko AS, Kantorow M. Autophagy and mitophagy participate in ocular lens organelle degradation. Experimental Eye Research. 116: 141-50. PMID 24012988 DOI: 10.1016/J.Exer.2013.08.017 |
0.605 |
|
2012 |
Basu S, Rajakaruna S, Menko AS. Insulin-like growth factor receptor-1 and nuclear factor κB are crucial survival signals that regulate caspase-3-mediated lens epithelial cell differentiation initiation. The Journal of Biological Chemistry. 287: 8384-97. PMID 22275359 DOI: 10.1074/Jbc.M112.341586 |
0.623 |
|
Show low-probability matches. |